EW vs HCA: fair value comparison
Edwards Lifesciences Corporation and HCA Healthcare, Inc. · Updated 2026-09-06
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, EW currently sits closer to the top of our discount ranking. EW carries the stronger quality grade.
| EW | HCA | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $89.90 | $405.00 |
| 12-month range | $81.26–$90.74 | $370.96–$532.92 |
| Sector rank | #50 of 113 Healthcare | #52 of 113 Healthcare |
| Quality grade | A | C |
| Leverage | Low | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The bottom quarter |
Full single-stock breakdowns: EW fair value analysis · HCA fair value analysis